OTTAWA, Ontario, Aug. 16, 2017 /Weed Wire/ — Tetra Bio-Pharma Inc. (” Tetra ” or the ” Company “) (CSE:TBP)(CSE:TBP.CN)(CNSX:TBP)(TSX VENTURE:TBP)(OTCQB:TBPMF), today announced that its common shares have been approved for trading on the TSX Venture Exchange and that it has applied for voluntary delisting of its common shares from the Canadian Securities Exchange (CSE).
Tag Archives: Tetra Bio-Pharma
Tetra Bio-Pharma Announces Stock Option Grant to CEO
OTTAWA, Ontario, July 25, 2017 /Weed Wire/ — Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (CSE:TBP)(CSE:TBP.CN)(CNSX:TBP)(OTCQB:TBPMF), announces that it has made a grant of stock options under its stock option plan to the newly appointed Chief Executive Officer, Bernard Fortier to acquire a total of 400,000 common shares of the Company.
Tetra Bio-Pharma Accelerates Growth Strategy with Appointment of Bernard Fortier as CEO
OTTAWA, Ontario July 24, 2017 /Weed Wire/ — Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (CSE:TBP)(CSE:TBP.CN)(CNSX:TBP)(OTCQB:TBPMF) today announced that it has strengthened its management team with the appointment of Bernard Fortier to the position of Chief Executive Officer, effective today, July 24, 2017.
Tetra Bio-Pharma Signs Letter of Intent with Constance Therapeutics
OTTAWA, Ontario, July 19, 2017 /Weed Wire/ — Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (CSE:TBP)(CSE:TBP.CN)(CNSX:TBP)(OTCQB:TBPMF), announced today it has signed a Letter of Intent (LOI) with Constance Therapeutics, Inc. of San Francisco, California, USA, for the clinical development and commercialization in Canada of its signature standardized, patent-pending, medicinal cannabis extract products.
MJIC Marijuana Index Rebalances and Adds 7 New Cannabis Companies
LOS ANGELES, July 13, 2017 /Weed Wire/ — MJIC Inc. has completed its quarterly rebalancing of the Marijuana Index, adding seven new cannabis companies to the Canadian Marijuana Index.
Tetra Bio-Pharma Announces Results of Voting at Annual Shareholders’ Meeting & Provides a Corporate Update
OTTAWA, Ontario, July 11, 2017 /Weed Wire/ — Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (CSE:TBP)(CSE:TBP.CN)(CNSX:TBP)(OTCQB:TBPMF), is pleased to announce the results of the vote at its July 10, 2017 annual shareholders’ meeting.
Tetra Bio-Pharma Strengthens its Position on Bringing Marijuana to Patients in a Form Acceptable to Health Care Professionals
OTTAWA, Ontario, July 5, 2017 /Weed Wire/ — Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (CSE:TBP)(CSE:TBP.CN)(CNSX:TBP)(OTCQB:TBPMF), today announced that it has strengthened its position on bringing marijuana to patients in the form of a prescription drug.
Tetra Bio-Pharma Appoints Aphria CFO, Mr. Carl Merton to the Board of Directors
OTTAWA, Ontario, June 14, 2017 /Weed Wire/ — Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (CSE:TBP) (OTCQB:TBPMF), today announced that it has appointed Mr. Carl A. Merton to the Board of Directors effective immediately.
World of Cannabis Interview: Tetra Bio Pharma
In this World of Cannabis interview, watch Caroline Cahill, Managing Editor of Marijuana Industry News, interview Ryan Brown, Co-founder of Tetra Bio Pharma.
Aphria Makes $1,000,000 Investment in Tetra Bio-Pharma via Private Placement to Fund PhytoPain Pharma Clinical Trials
OTTAWA, Ontario, Dec. 6, 2016 /Weed Wire/ — Tetra Bio-Pharma Inc. (“Tetra Bio” or “the Company”) (OTC PINK:GRPOF) is conducting a non-brokered private placement with Aphria Inc. (OTCQB:APHQF).